We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

PSN:NYSEParsons Corporation Analysis

Data as of 2026-09-05 - not real-time

$47.58

Latest Price

9/10Risk

Risk Level: High

Executive Summary

At $47.58, Parsons Corporation shows a bearish moving-average alignment, with shorter averages beneath longer ones. The last 30 days have lost 19.0%. Relative strength is 47.2 — neutral — and the MACD signal is bullish. Price has been bracketed by support at $45.15 and resistance at $49.89.
On valuation the read is undervalued — earnings multiple of 32.8 versus a 33.2 sector average, in line with the peer group. Consensus targets land 24.8% above where the shares trade now.
Risk scores 9 out of 10, which is high for this asset class. With 30-day volatility of 135.8%, a beta of 1.29 and a maximum drawdown of 54.8%, position sizing matters more than entry timing here. The wider market backdrop reads extreme greed at 95 on the fear-greed composite.
The horizons line up on hold — conviction 1 out of 10.

Top Market Events

Parsons NYSE:PSN has become the focus of multiple shareholder investigations.Updated Aug 6, 2026 0 Parsons Corporation shares dropped 35% after the Company reported a Q2 CY2026 net loss and cut...Infrastructure and defense services provider Parsons NYSE:PSN in Q2 CY2026, with sales flat year on year at $1.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 1/10

Key Factors

  • Short-term moving averages stacked below long-term ones
  • Trading below the 200-day average of 58.87
  • MACD momentum is positive

Medium Term

1–3 years
Neutral
Model confidence: 1/10

Key Factors

  • Short-term moving averages stacked below long-term ones
  • P/E of 32.8 versus sector average of 33.2
  • Trading below the 200-day average of 58.87

Long Term

> 3 years
Neutral
Model confidence: 1/10

Key Factors

  • P/E of 32.8 versus sector average of 33.2
  • Analyst targets imply +24.8% versus the current price
  • Revenue contracting at -0.5%

Key Metrics & Analysis

Financial Health

Revenue Growth-0.50%
Profit Margin2.50%
P/E Ratio32.8
ROE8.24%
ROA3.62%
Debt/Equity59.88
P/B Ratio1.9
Op. Cash Flow$384.3M
Free Cash Flow$213.5M
Industry P/E33.2

Technical Analysis

TrendBearish
RSI47.2
Support$45.15
Resistance$49.89
MA 20$47.53
MA 50$51.01
MA 200$58.87
MACDBullish
VolumeStable
Fear & Greed Index95.48

Valuation

Fair Value$12.39
Target Price$59.36
Upside/Downside24.77%
GradeUndervalued
TypeBlend

Risk Assessment

Beta1.29
Volatility135.81%
Sector RiskHigh
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.